Health TrialsbyHealthPanel

Correlation Between Acne Vulgaris and Lipid Profile Among Young Adults in Sohag Governorate

ConditionAcne Vulgaris
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-45
SponsorSohag University

About this trial

Acne vulgaris is the most common skin condition affecting late adolescents worldwide.1 The prevalence of acne is said to be 85% in adults aged 12 to 25 years.2 Almost all teenagers between 15 and 17 years report having some degree of acne.3 Estimates of the lifetime occurrence of acne in the literature range from 0.1%4 to as high as 85.1%5 in the general population, depending on the age range, region, and method of sampling. Overall, acne is more common in women,8,9 but in some literature the prevalence is approximately equal in men and women.10,11

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

age- and sex-matched healthy volunteers, not taking any medicine, and having no personal or family history of acne.

Disqualifiers

: reluctance to take part in the study, pregnancy or lactation

intake of oral contraception or hormone therapy, history of taking any medications that affect lipid metabolism or oral isotretinoin

and systemic diseases that affect the metabolism of lipids, such as uncontrolled diabetes, hypothyroidism, nephrotic syndrome, end-stage renal failure, HIV, familial hypercholesterolemia, and metabolic syndrome.

Trial design

Design model

Single group

Treatments tested in this trial

  • lipid profile

    Diagnostic test

    The blood samples were taken to measure lipid profile levels as triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL), and high-density lipoprotein cholesterol (HDL) and VLDL values.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

lipid profile (TG)

The blood samples were taken to measure lipid profile levels as triglycerides (TG)

Time frame
6 months
2

lipid profile (HDL)

The blood samples were taken to measure lipid profile levels as HDL

Time frame
6 months
3

lipid profile (VLDL)

The blood samples were taken to measure lipid profile levels as VLDL

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: